Ocugen

Ocugen Quick Ratio

Quick Ratio (Acid Test) of Ocugen (OCGN) as of Nov 20, 2026.

Quick Ratio

-

Last updated:

Quick Ratio (Acid Test) of Ocugen is 2026 - . Quick Ratio (Acid Test) of Ocugen was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ocugen Stock analysis

What does Ocugen do? Ocugen Inc is a US-based biopharmaceutical company specializing in the development and commercialization of innovative therapeutics and vaccines. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania. It has a strong pipeline of products in various stages of development, with a focus on treating eye diseases and other medical conditions. Ocugen has also entered into partnerships for the development and marketing of COVID-19 vaccines, including Covaxin. Overall, Ocugen Inc is expected to be a significant player in the biopharmaceutical industry in the coming years. Ocugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ocugen stock

On Eulerpool you can find the complete historical development of Quick Ratio (Acid Test) Ocugen since 2006 – with annual values, charts, and detailed analysis.

The Quick Ratio measures liquidity by comparing liquid assets to current liabilities, excluding inventory. It is a more conservative measure than the current ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Quick Ratio (Acid Test)'s Ocugen with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Ocugen

All Key Metrics — Ocugen